TIDMAGR

RNS Number : 5119Z

Assura PLC

15 September 2022

15 September 2022

Assura plc

Scrip Calculation Price

Assura plc ("the Company") announces, in accordance with the terms and conditions of the Company's Scrip Dividend Scheme ("the Scheme"), that the Scrip Calculation Price in respect of the quarterly interim dividend proposed to be paid on 12 October 2022, is 63.73 pence. This is the average closing mid-market price of an ordinary share in the Company for the five dealing days commencing with, and including, the ex-dividend date of 8 September 2022.

If you wish to receive this quarterly interim dividend in cash, you do not need to take any action.

If you wish to participate in the Scheme and receive New Shares instead of your cash dividend, you should complete a Mandate, as follows:

-- If you hold your Ordinary Shares in certificated form, and if you have not already done so, you should complete the Mandate Form (which is available to download from Assura's website www.assuraplc.com) in accordance with the instructions printed thereon and return it to Link Group at 10(th) Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL by no later than 4.30 p.m. (London time) on 29 September 2022. The Mandate Form will remain in force for any future dividends in respect of which a Scrip Dividend Alternative is offered, until such time as the Mandate Form is cancelled.

-- If you hold your Ordinary Shares in uncertificated form via the CREST System, you can only elect to receive dividends in the form of New Shares by submitting a CREST Dividend Election Input Message via the CREST System. Evergreen elections will not be permitted. This means that if you wish to receive New Shares instead of cash as a matter of routine whenever a Scrip Dividend Alternative is offered, you must complete and submit a CREST Dividend Election Input Message on each occasion, otherwise you will receive the relevant dividend in cash.

If you have any questions about the Scheme or how it operates, you can contact our Registrar, Link Group, at the address above or by telephone on 0371 664 0321. Lines are open between 9.00am and 5.30pm Monday to Friday, excluding public holidays.

Based upon the above Scrip Calculation Price, if all eligible Shareholders were to elect to take up their full entitlement to New Shares in respect of this quarterly interim dividend, approximately 36,218,029 New Shares would be issued. This would represent approximately 1 per cent. of the Company's issued share capital as at today's date. The total cash cost of this quarterly interim dividend if no Shareholders were to elect to take up their entitlement (and therefore no New Shares were to be issued) would be approximately GBP23.1 million.

Words and expressions defined in the circular dated 9 December 2015 in relation to the Scheme bear the same meanings in this announcement.

This interim dividend will be paid as 100% Property Income Distribution ("PID"). F orms to register for gross PIDs are available on the Company's website. Please click here for PID Forms .

- Ends -

For more information, please contact:

 
  Assura plc                          Tel: 01925 945354 
   Orla Ball, Company Secretary        E mail: Investor@assura.co.uk 
   David Purcell, Investor Relations 
   Director 
 
    FGS Global                          Tel: 0207 251 3801 
    Gordon Simpson                      Email: Assura@fgsglobal.com 
    James Thompson 
 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which almost seven million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2022, Assura's portfolio was valued at GBP2,752 million.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DIVSFMFWLEESEIU

(END) Dow Jones Newswires

September 15, 2022 02:00 ET (06:00 GMT)

Assura (LSE:AGR)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Assura Charts.
Assura (LSE:AGR)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Assura Charts.